Farber Lipogranulomatosis: Clinical Trials

3 trials for Farber Lipogranulomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 withdrawn. .

Follow Farber Lipogranulomatosis: new trials by email Literature Review of Farber Lipogranulomatosis trials Research Report on Farber Lipogranulomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital
Mucopolysaccharidoses, Progressive Pseudorheumatoid Dysplasia
Not yet recruitingAssiut University352025-09-012025-09-15
Biomarker for Farber Disease (BioFarber)
Farber's Lipogranulomatosis, Ceramidase Deficiency
WithdrawnCENTOGENE GmbH Rostock2018-08-202023-02-13
Farber Disease Natural History Study
Farber Disease, Farber's Disease
CompletedSumitomo Pharma Switzerland GmbH452017-11-222020-01-18

Narrower conditions

Lysosomal Storage Diseases (2)  ·  Arthropathy, progressive pseudorheumatoid, of childhood (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Central Nervous System Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Erdheim-Chester Disease (1)  ·  Genetic Diseases, Inborn (1)  ·  Hepatomegaly (1)  ·  Hyaline Fibromatosis Syndrome (1)  ·  Infant, Newborn, Diseases (1)  ·  Lipid Metabolism Disorders (1)  ·  Lipidoses (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Lipid Metabolism, Inborn Errors (3)  ·  Lysosomal Storage Diseases, Nervous System (3)  ·  Nervous System Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Lipid Metabolism Disorders (2)  ·  Lipidoses (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Sponsors

Assiut University (1)  ·  CENTOGENE GmbH Rostock (1)  ·  Sumitomo Pharma Switzerland GmbH (1)

Countries

Egypt (2)  ·  Germany (2)  ·  India (2)  ·  Argentina (1)  ·  Canada (1)  ·  Italy (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Peter Bauer, Prof. (1)

Results publications

PMID 22210669, PMID 23666771, PMID 26388606, PMID 26610319, PMID 28595941, PMID 30805524, PMID 32449975, PMID 34430024, PMID 3591830, PMID 37927741, PMID 39246942, PMID 9561014